Occudo Quantitative Strategies LP Immuno Gen, Inc. Transaction History

Occudo Quantitative Strategies LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$3.15 - $5.76 $245,104 - $448,191	77,811 New	77,811 $350,000
Q4 2021 Feb 14, 2022	SELL	$4.75 - $7.5 $51,627 - $81,517	-10,869 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$5.02 - $6.59 $54,562 - $71,626	10,869 New	10,869 $62,000
Q1 2021 May 14, 2021	SELL	$6.5 - $10.53 $324,109 - $525,057	-49,863 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$3.7 - $7.66 $184,493 - $381,950	49,863 New	49,863 $322,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.